REFILE- REGENERON PHARMACEUTICALS INC. <REGN.O>: MORGAN STANLEY CUTS TARGET PRICE TO $754.00 FROM $755.00 (FIXES COMPANY NAME)
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.